CLINICAL_TRIALS
trial_result
· 2020-08-20
Clinical Trial Update: A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung [Phase 2]
Summary
Phase 2 trial assessing safety and efficacy of Farletuzumab in adenocarcinoma of the lung has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Morphotek | Conditions: Adenocarcinoma of the Lung | Phase 2 | Status: COMPLETED | Results posted: 2020-08-20